Clinical Trials Browser

INDUSTRY × Has results × RRx-001 × Clear all

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT03515538 2024-11-04

PREVLAR

Phase 2 Completed

53 enrolled 15 charts

Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT01359982 2024-11-01

DINAMIC

Phase 1 Completed

26 enrolled 11 charts

Lymphoma, Neoplasms

NCT02096354 2024-10-15

ROCKET

Phase 2 Completed

62 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT02452970 2024-04-24

EPIC

Phase 2 Terminated

4 enrolled 6 charts

Gastrointestinal

Cholangiocarcinoma